Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 15,500 shares at $9.41 ($144K) on 2018-11-21, disclosed to the SEC on 2018-11-26.
Open-market sale of $144k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.08 | 7,000 | $64K | 44.0% |
| 2 | $9.41 | 5,000 | $47K | 32.6% |
| 3 | $9.66 | 3,500 | $34K | 23.4% |
| Total | $9.32 avg | 15,500 | $144K | 100% |
| Filing → |